Tobii (TOBII) Q2 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2025 earnings summary
16 Nov, 2025Executive summary
Net sales rose 41% year-over-year in Q2 2025 to SEK 284 million, with organic growth of 54%, driven by a major volume order in Integrations and a new contract with Dynavox Group.
EBIT improved to SEK 24 million from SEK -66 million, including a SEK 48 million write-down of intangible assets and significant operational savings.
Free cash flow turned positive at SEK 71 million, up SEK 192 million year-over-year, reflecting cost savings and reduced R&D investments.
Cost reduction program delivered SEK 263 million in operational savings, exceeding the original SEK 200 million target.
Launched Glasses X, a cloud-native wearable eye tracker, and achieved EU homologation for the single-camera DMS/OMS solution, strengthening product offerings and market credibility.
Financial highlights
Q2 gross margin increased to 83% from 79% year-over-year, mainly due to product mix changes.
EBIT improved by SEK 90 million to SEK 24 million, with a one-time SEK 48 million intangible asset write-down.
Profit for Q2 was SEK 4 million, up from a loss of SEK 78 million; EPS improved to SEK 0.02 from -0.33.
Cash and cash equivalents at period end were SEK 150 million, with net debt at SEK 242 million.
For H1 2025, net sales grew 33% to SEK 482 million, with organic growth of 32%.
Outlook and guidance
Management expects continued quarter-to-quarter variation in results but remains committed to sustained improvement and long-term profitability.
Focus remains on profitability, financial strength, and strengthening product offerings.
Financial targets include positive free cash flow and a 10% EBIT margin for full-year 2026, and 20% EBIT margin for 2028.
Latest events from Tobii
- Cost savings and a DMS deal offset weak sales and large write-offs, boosting cash flow.TOBII
Q4 20254 Feb 2026 - Q2 sales rose 8% on acquisition, but organic decline and losses prompt cost-cutting focus.TOBII
Q2 20243 Feb 2026 - Q3 net sales up 40% and EBIT loss narrowed, with cost cuts and integration synergies boosting outlook.TOBII
Q3 202418 Jan 2026 - Record EBIT and strong margins in Q4, with cost savings and Autosense growth despite organic declines.TOBII
Q4 20249 Jan 2026 - First positive Q1 EBIT, 23% sales growth, and strong cash flow from cost reductions and divestments.TOBII
Q1 202521 Nov 2025 - Net sales fell 25% in Q3, but gross margin and free cash flow improved amid financing risks.TOBII
Q3 202524 Oct 2025